Holen Sie sich die Stockscreener-App
5.43
0.56%
0.03
Casi Pharmaceuticals Inc Aktie (CASI) Neueste Nachrichten
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Short Interest Update - MarketBeat
Objective long/short (CASI) Report - Stock Traders Daily
Renaissance Technologies LLC Acquires 4,000 Shares of CASI Pharmaceuticals, Inc. (NASDAQ:CASI) - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
(CASI) Trading Report - Stock Traders Daily
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200 Day Moving Average of $4.67 - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200-Day Moving Average of $4.67 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) shareholders are still up 129% over 1 year despite pulling back 22% in the past week - Yahoo Finance
CASI Pharmaceuticals (NASDAQ:CASI) pulls back 22% this week, but still delivers shareholders solid 129% return over 1 year - Simply Wall St
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Passes Above 200 Day Moving Average of $4.60 - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above Two Hundred Day Moving Average of $4.60 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above 200 Day Moving Average of $4.57 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Stock Crosses Above 200-Day Moving Average of $4.57 - MarketBeat
CASI PHARMACEUTICALS TO PARTICIPATE IN THE 2024 H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE - BioSpace
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above 200 Day Moving Average of $4.48 - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above 200-Day Moving Average of $4.48 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Stock Passes Above 200-Day Moving Average of $4.46 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above Two Hundred Day Moving Average of $4.46 - MarketBeat
Short Interest in CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Declines By 6.9% - Defense World
(CASI) Technical Pivots with Risk Controls - Stock Traders Daily
CASI Pharmaceuticals (NASDAQ:CASI) Announces Quarterly Earnings Results - Defense World
Idg Accel China Growth Fund Iii L.p. Net Worth (2024) - GuruFocus.com
CASI Stock Earnings: CASI Pharmaceuticals Beats EPS, Misses Revenue for Q2 2024 - MSN
CASI PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2024 BUSINESS AND FINANCIAL RESULTS - PR Newswire
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Passes Above 200 Day Moving Average of $4.47 - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Share Price Crosses Above Two Hundred Day Moving Average of $4.47 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above Two Hundred Day Moving Average of $4.44 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Stock Passes Above 200-Day Moving Average of $4.44 - MarketBeat
StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com - Defense World
3 Promising Biotech Stocks You Can Pick Up for Less Than $10 - InvestorPlace
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Sees Large Decline in Short Interest - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200-Day Moving Average of $4.41 - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Crosses Above 200 Day Moving Average of $4.41 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Receives New Coverage from Analysts at StockNews.com - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by Analysts at StockNews.com - Defense World
Head-To-Head Analysis: Lantern Pharma (NASDAQ:LTRN) versus CASI Pharmaceuticals (NASDAQ:CASI) - Defense World
CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS - StockTitan
StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) versus Lantern Pharma (NASDAQ:LTRN) Financial Comparison - American Banking and Market News
CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated by Analysts at StockNews.com - Defense World
Short Interest in CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Increases By 771.1% - American Banking and Market News
CASI Pharmaceuticals (NASDAQ:CASI) Shares Pass Above Two Hundred Day Moving Average of $4.42 - Defense World
CASI Pharmaceuticals (NASDAQ:CASI) Stock Price Passes Above Two Hundred Day Moving Average of $4.42 - MarketBeat
CASI Pharmaceuticals (NASDAQ:CASI) Now Covered by StockNews.com - Defense World
CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host Conference Call August 12, 2021 - Quantisnow
CASI Pharmaceuticals appoints Daniel Lang, MD as CFO (NASDAQ:CASI) - Seeking Alpha
CASI Pharmaceuticals announces appointment of Daniel Lang, MD as CFO and SVP - PR Newswire
CASI PHARMACEUTICALS TO REPORT SECOND QUARTER 2022 FINANCIAL RESULTS AND HOST ... - Quantisnow
8.06%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):